Inmazeb
atoltivimab, maftivimab, and odesivimab-ebgn
- Strength
- 241.7 mg/14.5mL, 241.7 mg/14.5mL, 241.7…
- Form
- Injection, Solution
Regeneron Pharmaceuticals, Inc.
Not stocked by us — reference only
atoltivimab, maftivimab, and odesivimab-ebgn
Listed by Regeneron Pharmaceuticals, Inc.
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 61755-019 |
| FDA application | BLA761169 |
| RxNorm concept | 2461536 |
| Package sizes listed | 1 |
| Marketed since | July 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
atoltivimab, maftivimab, and odesivimab-ebgn
Regeneron Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.